Company intelligence / Profile preview

Kunshan Preti Pharmaceutical

Chongqing, Chongqing, China

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Chongqing Purui Biopharmaceutical Technology Co., Ltd. (formerly known as Nuoweidi (Kunshan) Chemical Co., Ltd.) is a Chinese biotechnology company specializing in pharmaceutical chemical synthesis, process route development, and custom synthesis of active pharmaceutical ingredients (APIs) and intermediates. The company operates a dedicated R&D center in Chongqing and collaborates closely with local academic institutions to support process optimization and pilot-scale production. Purui Biopharmaceutical provides high-tech chemical products and technology transfer services to global pharmaceutical and fine chemical enterprises.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Kunshan Preti Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kunshan Preti Pharmaceutical.

Explore the full profile